Site Search
394 Results (showing 1 - 25)
Oct 29, 2004
Ciphergen Stock Loses Ground Gained on News of BioSepra Divestiture
Oct 29, 2004
... Subscribers: click headline for more
Oct 29, 2004
Although RNA interference has revolutionized the lifesciences, the technology is still relatively unknown to the general population.
Oct 29, 2004
As interest in RNA interference increases with the start of the first ever clinical trial of an siRNA-based drug, and as efforts in related areas forge ahead, the time seems right to try to bring together the key oligonucleotide therapeutics players in a bid to nurture and grow the field.... Subscribers: click headline for more
Oct 29, 2004
... Subscribers: click headline for more
Oct 29, 2004
At A Glance
Name: Rong Wang
Position: Associate professor, Mount Sinai School of Medicine’s Department of Human Genetics
Oct 29, 2004
Gregory Gosch has been named vice president of marketing for Luminex. Before joining Luminex, Gosch served as senor director of sales and marketing for Nanogen, headquartered in San Diego.
Oct 29, 2004
... Subscribers: click headline for more
Oct 29, 2004
Strong Sales in Invitrogen s BioDiscovery Unit Spurred 30-Percent Revenue Growth
NEWSBRIEF
Oct 29, 2004
BEIJING -- During one and a half days of workshops here to discuss results of the pilot phase of the Human Proteome Organization s Plasma Protoeme Project, plasma researchers grappled to decide which techniques should be standardized to come up with harmonious data across laboratories, and how some techniques such as mass spectrometry can be standardized...Subscribers: click headline for more
Oct 29, 2004
As interest in RNA interference increases with the start of the first ever clinical trial of an siRNA-based drug, and as efforts in related areas forge ahead, the time seems right to try to bring together the key oligonucleotide therapeutics players in a bid to nurture and grow th
Oct 29, 2004
BEIJING -- While leaders of various Human Proteome Organization initiatives struggled to standardize techniques during pilot phase studies, Lee Hartwell, the first key note speaker at the HUPO conference, held here this week, urged researchers not to wait until other matters are settled to begin correlating proteome changes with disease and health research...Subscribers: click headline for more
Oct 29, 2004
Bruker Daltonics, Eppendorf
Premium
Bruker Daltonics in conjunction with Eppendorf announced this week the launch of its Prespotted AnchorChip, a disposable MALDI chip designed for use in LC-MALDI proteomics experiments.
Oct 29, 2004
Although RNA interference has revolutionized the lifesciences, the technology is still relatively unknown to the general population. All that may change, at least for the average pet lover, if Los Angeles-based Allerca achieves its goal of using the gene-silencing technology to develop a hypoallergenic cat.... Subscribers: click headline for more
Oct 29, 2004
... Subscribers: click headline for more
Oct 28, 2004
Novartis, Broad Institute to Study Genetics of Diabetes; Data Will Be Made Public
NEWSBRIEF